AlphaMadera's AlphaVal page computes The Sherwin-Williams Company's fair value using a multi-method blend (DCF, comparable-multiples, and Graham-style intrinsic value), then compares it to the current market price to flag SHW as undervalued, fairly valued, or overvalued.

What is The Sherwin-Williams Company's fair value?

Fair value for SHW is a model output combining discounted cash flow projections, peer-group multiples, and a Graham number floor. The live AlphaVal page shows the blended fair value alongside each method's individual estimate.

How does AlphaMadera value SHW?

AlphaVal uses three primary techniques: a five-year discounted-cash-flow projection with terminal multiple, peer-group multiple analysis (P/E, EV/EBITDA, P/S), and Graham's defensive-investor intrinsic-value formula. Inputs come from SHW's most recent reported fundamentals.

SHW - The Sherwin-Williams Company

Price: -- -- | CONSENSUS: Buy DETAILS | PRICE TARGET: $375.00 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

Stable Earnings Power 65% confidence

Primary model: P/Adj-EPS × Normalized Multiple

Valuation Signal Overvalued Strong

Trading 43.1% above fair value

Current Price $333.99

Bear Case $186.66 44.1% downside ($186.66 - $333.99) / $333.99 = -44.1% $11.51 × 12x P/E

Fair Value $233.33 30.1% downside ($233.33 - $333.99) / $333.99 = -30.1% $11.51 × 15x P/E

Bull Case $279.99 16.2% downside ($279.99 - $333.99) / $333.99 = -16.2% $11.51 × 18x P/E

Adjust Assumptions

P/E Multiple

15.0x

Adjusted EPS

11.51$

Key Value Driver

Normalized P/E multiple (15x base case)

Implied Market Multiple 29.0x

Plain-Language Summary

Our base-case estimate uses a valuation based on adjusted earnings per share and a normalized price-to-earnings multiple. We then blend that result with the average analyst price target of $375.00 from 38 analysts, using a 30% weight on analyst consensus. That produces an estimated intrinsic value of $233.33 per share.

Warnings

ℹ Dividend-based valuation: $259.78 (above our primary estimate by 51%). Large gaps may signal the dividend doesn't reflect full earning power.

ℹ Wall Street's average price target is $375.00 (from 38 analysts). Our estimate is 54% below the consensus -- consider that gap carefully.

Key Risks

Growth DCF inappropriate — terminal value assumptions dominate
EV/EBITDA misleading for regulated businesses where capex is mandated
Regulatory risk is a fat tail not visible in normal multiples